How food affects Y-4 tablets in healthy people
Treatments studied
This study tests how food affects the way a new medicine (Y-4 tablet) is processed in the body. It is looking for healthy volunteers to take a single dose of the study drug and have their blood levels checked over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 45 years old.
- Your weight is at least 110 pounds (50 kg) for men or 99 pounds (45 kg) for women, and your body mass index (BMI) is between 19 and 28.
- You do not have any long-term health conditions like heart, kidney, liver, or mental health disorders.
- You are not taking any regular medications (including over-the-counter, supplements, or recreational drugs).
- You do not smoke, drink heavily, or consume a lot of caffeine (more than 2 cups of coffee per day).
- You are willing to avoid certain foods (like grapefruit, mango, or caffeine) and follow a set diet during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a new tablet called Y-4 interacts with pregabalin and riluzole in healthy people. It helps doctors understand how these drugs work together in the body.
This early-phase study tests how a new medicine (Y-4) moves through the body when taken with two other drugs (pregabalin and riluzole) in healthy people. It helps doctors understand the safety and dosing before testing in patients.
This trial tests the safety and how the body processes a new medicine called Y-4. Healthy adults ages 18 to 45 can join to help researchers understand how the drug works and if it has any side effects.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This study tests a new medicine called Y-3 in people with mild or moderate liver problems and in healthy volunteers. It aims to see how the body handles the drug, so doctors can learn the right dose for people with liver issues.
Hear when a new Healthy Male and Female Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.